A new study found that weight-loss medications like Ozempic and Mounjaro are not as effective in a “real-world” setting ...

For patients with obesity initiating pharmacotherapy with semaglutide or tirzepatide, weight loss at one year is 8.7 percent ...

Women who use an oral contraceptive might want to consider using a back-up method after starting a weight loss drug.

Researchers have identified the brain cells responsible for the weight-loss effects of semaglutide without triggering its undesirable side effects. This discovery paves the way for more targeted ...

A new study published in The Lancet journal showed that patients with type 2 diabetes and symptomatic peripheral arterial ...

Real-world results for blockbuster weight-loss meds like Ozempic, Wegovy and Zepbound aren't as impressive as those promised ...

Compounded GLP-1s are still accessible on telehealth sites, despite an agreement with Eli Lilly to cease copycat sales.

Experts say that semaglutide and tirzepatide can help patients with heart failure lose weight, but limited NHS access is ...

In a 36-week study, semaglutide was found to aid in weight loss for people with schizophrenia without worsening psychotic ...

Semaglutide, widely used to treat diabetes and obesity, was associated with more than double the risk of developing ...